Edition:
United States

Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

338.10USD
20 Oct 2017
Change (% chg)

$-4.32 (-1.26%)
Prev Close
$342.42
Open
$343.00
Day's High
$343.31
Day's Low
$333.93
Volume
1,909,267
Avg. Vol
1,364,994
52-wk High
$348.84
52-wk Low
$244.28

Select another date:

Thu, Oct 5 2017

BRIEF-Biogen updates on new data on treatment with Spinraza

* Presented new data showing earlier initiation of treatment with Spinraza may improve motor function outcomes in infants with spinal muscular atrophy

BRIEF-Biogen appoints Sanjay Jariwala as SVP

* Biogen appoints Sanjay Jariwala as SVP, worldwide medical Source text for Eikon: Further company coverage:

BRIEF-Ionis earns $40 million Spinraza regulatory milestone payment from Biogen

* Ionis earns $40 million Spinraza regulatory milestone payment from Biogen

Samsung, Biogen version of AbbVie's Humira approved in Europe

A biosimilar version of AbbVie Inc's blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics, was approved by European Union regulators, the partners said on Thursday.

UPDATE 1-Samsung, Biogen version of AbbVie's Humira approved in Europe

Aug 24 A biosimilar version of AbbVie Inc's blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics , was approved by European Union regulators, the partners said on Thursday.

BRIEF-Imraldi, Biogen's Adalimumab Biosimilar referencing Humira, is approved in EU

* Imraldi(®), Biogen's Adalimumab Biosimilar referencing Humira(®), is approved in European Union

BRIEF-Paulson & Co takes share stake in Apple, dissolves share stake in Sarepta, Biogen

* Ups share stake in T-Mobile US Inc by 46.1 percent to 6.1 million shares - SEC filing

BRIEF-Temasek Holdings takes stake in JPMorgan, Biogen, Celgene

* Temasek Holdings (Private) Ltd takes share stake in JPMorgan Chase & Co of 264,337 shares

BRIEF-Biogen appoints Anabella Villalobos senior vice president, Biotherapeutic & Medicinal Sciences

* Biogen appoints Anabella Villalobos senior vice president, Biotherapeutic & Medicinal Sciences Source text for Eikon: Further company coverage:

BRIEF-Abarca Health signs reimbursement contract with Biogen for select products

* Signed value-based reimbursement contract with Biogen for select products in Biogen's leading multiple sclerosis portfolio​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Select another date: